Cargando…

PI3Kδ inhibition elicits anti-leukemic effects through Bim-dependent apoptosis

PI3Kδ plays pivotal roles in the maintenance, proliferation and survival of malignant B-lymphocytes. Although not curative, PI3Kδ inhibitors (PI3Kδi) demonstrate impressive clinical efficacy and, alongside other signaling inhibitors, are revolutionizing the treatment of hematological malignancies. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carter, M J, Cox, K L, Blakemore, S J, Turaj, A H, Oldham, R J, Dahal, L N, Tannheimer, S, Forconi, F, Packham, G, Cragg, M S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467045/ https://www.ncbi.nlm.nih.gov/pubmed/27843137 http://dx.doi.org/10.1038/leu.2016.333

Ejemplares similares

The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo
por: Palazzo, Adam, et al.
Publicado: (2018)

BIM and NOXA are mitochondrial effectors of TAF6δ-driven apoptosis
por: Delannoy, Aurélie, et al.
Publicado: (2018)

E4BP4 facilitates glucocorticoid-evoked apoptosis of human leukemic CEM cells via upregulation of Bim
por: Beach, Jessica A, et al.
Publicado: (2011)

PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors
por: Yahiaoui, Anella, et al.
Publicado: (2017)

Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells
por: Cai, Zhigang, et al.
Publicado: (2020)

Bim plays apoptosis offense
por: Powell, Kendall
Publicado: (2007)

BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells
por: Sharma, A, et al.
Publicado: (2013)

BIM-mediated apoptosis and oncogene addiction
por: Li, Yulin, et al.
Publicado: (2016)

ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype
por: Lucena-Araujo, Antonio R., et al.
Publicado: (2016)

Oncogenic Kit Triggers Shp2/Erk1/2 Pathway to Down-Regulate the Pro-Apoptotic Protein Bim and to Promote Apoptosis Resistance in Leukemic Cells
por: Selimoglu-Buet, Dorothée, et al.
Publicado: (2012)

Bim is a crucial regulator of apoptosis induced by Mycobacterium tuberculosis
por: Aguiló, N, et al.
Publicado: (2014)

MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis
por: Nguyen, Hai Vu, et al.
Publicado: (2023)

The Treatment of Activated PI3Kδ Syndrome
por: Coulter, Tanya I., et al.
Publicado: (2018)

Combined inhibition of the PI3K/mTOR/MEK pathway induces Bim/Mcl-1-regulated apoptosis in pancreatic cancer cells
por: Burmi, Rajpal S., et al.
Publicado: (2018)

Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors
por: Isoyama, Sho, et al.
Publicado: (2023)

Implementation of Space Charge Forces in BimBim
por: Gottlob, Emmanuel
Publicado: (2017)

Effect of cAMP signaling on expression of glucocorticoid receptor, Bim and Bad in glucocorticoid-sensitive and resistant leukemic and multiple myeloma cells
por: Dong, Hongli, et al.
Publicado: (2015)

BIM's up first
por: Murphy, Daniel J., et al.
Publicado: (2014)

Protein Kinase Cδ Stimulates Proteasome-Dependent Degradation of C/EBPα during Apoptosis Induction of Leukemic Cells
por: Zhao, Meng, et al.
Publicado: (2009)

Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
por: Till, Kathleen J., et al.
Publicado: (2023)

Glucocorticoids can induce BIM to trigger apoptosis in the absence of BAX and BAK1
por: Dong, Li, et al.
Publicado: (2020)

Bim and Bmf Synergize To Induce Apoptosis in Neisseria Gonorrhoeae Infection
por: Kepp, Oliver, et al.
Publicado: (2009)

Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells
por: Kutuk, Ozgur, et al.
Publicado: (2010)

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ
por: Hassenrück, Floyd, et al.
Publicado: (2023)

Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor
por: Miller, Anna V., et al.
Publicado: (2013)

BIM Demystified
por: Race, Steve
Publicado: (2019)

Bim Demystified
por: Race, Steve
Publicado: (2012)

BIM Design
por: Garber, Richard
Publicado: (2014)

Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
por: Uehara, Mayuko, et al.
Publicado: (2017)

The BIM-manager: a practical guide for BIM project management
por: Baldwin, Mark, et al.
Publicado: (2019)

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
por: Rao, V. Koneti, et al.
Publicado: (2023)

A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration
por: Hagenbuchner, Judith, et al.
Publicado: (2013)

Hyper-activated PI3K-δ in immunodeficiency
por: Heurtier, Lucie, et al.
Publicado: (2015)

miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes
por: Qian, Li, et al.
Publicado: (2011)

Piperlongumine induces apoptosis and autophagy in leukemic cells through targeting the PI3K/Akt/mTOR and p38 signaling pathways
por: Wang, Hongfei, et al.
Publicado: (2018)

Trichonomas vaginalis Metalloproteinase Induces Apoptosis of SiHa Cells through Disrupting the Mcl-1/Bim and Bcl-xL/Bim Complexes
por: Quan, Juan-Hua, et al.
Publicado: (2014)

Epidermodysplasia verruciformis in a young adult with activated PI3Kδ syndrome
por: Donaldson, Stephanie L., et al.
Publicado: (2019)

Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax
por: Bajpai, R, et al.
Publicado: (2015)

FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons
por: Gilley, Jonathan, et al.
Publicado: (2003)

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition
por: Pepper, C, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_73i46i1r2siar2g0f4pekg708k